Meda LT, UAB - financials and debts

Company age: 12 y. 7 mo.

Update

Meda LT - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 1,242,104 1,339,395 1,594,106 1,613,605 2,074,835 2,846,811 3,189,329 4,603,187
Profit before tax 145,809 119,066 211,512 135,974 103,764 170,200 225,341 429,554
Net profit 122,485 99,559 177,636 113,130 86,222 138,411 187,310 355,719
Equity 182,118 255,888 327,641 360,467 364,639 441,690 519,294 645,013
Liabilities 289,733 475,010 342,172 463,448 441,151 458,729 654,877 584,503
Non-current assets 309,892 312,276 297,113 282,123 269,048 308,868 326,212 410,501
Current assets 175,664 417,761 368,232 509,757 501,117 579,839 824,064 822,283
Total assets 485,556 730,037 665,345 791,880 770,165 888,707 1,150,276 1,232,784
Taxes paid
STI taxes - - - - - 544,144 720,882 975,117
Social insurance contributions - - - - - 83,001 98,045 113,218
Financial indicators
Revenue change y/y +45.6% +7.8% +19.0% +1.2% +28.6% +37.2% +12.0% +44.3%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 25.2% 13.6% 26.7% 14.3% 11.2% 15.6% 16.3% 28.9%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 67.3% 38.9% 54.2% 31.4% 23.6% 31.3% 36.1% 55.1%
Profit margin Net profit margin. Shows the overall profitability of the company. 9.9% 7.4% 11.1% 7.0% 4.2% 4.9% 5.9% 7.7%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 11.7% 8.9% 13.3% 8.4% 5.0% 6.0% 7.1% 9.3%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 1.6 1.9 1.0 1.3 1.2 1.0 1.3 0.9
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 209,932 170,987 191,293 186,184 193,008 238,893 246,915 328,799

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Meda LT - Social security debts

From To Debt, €
2023-06-16 2023-06-22 0.01
2023-05-16 2023-06-08 0.01
2022-10-28 2022-11-10 0.11

Meda LT - VMI tax arrears

From To Overdue, €
2026-02-21 2026-02-21 4702.8
2025-05-24 2025-05-24 81.35

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Meda LT, UAB (company code 303245883), is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of EUR 4.60 million, up 44.3% year on year and 61.7% over two years, showing a strong upward sales trend. Net profit increased to EUR 355.7 thousand in 2025 from EUR 187.3 thousand in 2024 and EUR 138.4 thousand in 2023, while the net profit margin improved from 4.9% in 2023 to 5.9% in 2024 and 7.7% in 2025. The company also recorded profit before tax of EUR 429.6 thousand in 2025. At year-end 2025, total assets stood at EUR 1.23 million, equity at EUR 645.0 thousand, and liabilities at EUR 584.5 thousand. The balance sheet remained relatively balanced, with an equity ratio of 52.3% and debt-to-equity of 0.91. Efficiency indicators were also solid, with asset turnover of 3.73x, return on equity of 55.1%, and return on assets of 28.9%. Revenue per employee reached EUR 328.8 thousand, indicating strong productivity.